Research

EMBL researchers have developed a new AI tool, which, through a game of molecular laser tag, identifies cells that can shed light on the earliest origins of cancer Summary The human body relies on precise genetic instructions to function, and cancer begins when these instructions get scrambled. When cells accumulate genetic errors over time, they […]

EMBL researchers were awarded a BII foundation grant to support Model-MI – an in vitro model that mimics the maternal-fetal interface Pregnancy is a period of both excitement and concern for the healthy development of the foetus and the well-being of the expectant mother. During the ~40 weeks of gestation, many external factors constitute a danger for […]

Heidelberg researchers identify local outbreak indicators and develop new regional modeling approach Local factors such as seasonal temperature, the year-dependent water and vegetation index, and data on animal density can be used to predict regional outbreaks of avian flu in Europe. This is the finding of a research team led by epidemiologist, mathematician, and statistician […]

Philipp Uhl awarded for his work on new pharmaceutical forms and overcoming antibiotic resistance For his outstanding work in the field of pharmaceutical research, Junior Professor Dr Philipp Uhl has received the PHOENIX Pharmaceutical Science Award in the “Pharmaceutical Technology” category. Endowed with 10,000 euros per category, this prize is awarded annually by the Phoenix […]

A new method for building growth charts for children with rare diseases is being integrated into DECIPHER to help clinicians and families understand child development Summary Growth charts – used to track a child’s height and weight over time – help identify when a child’s growth is within a healthy range. But for children with […]

Researchers have built a 3D human blood-brain barrier in the lab and discovered a key role of brain pericytes in cerebral malaria disease Cerebral malaria is a deadly complication of Plasmodium falciparum infection. Despite cutting-edge research, effective anti-malarial drugs, and the promise of a vaccine, it still claims over half a million lives every year. Many survivors […]

Ladenburg, Germany, 23 October 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that HDP-101 (INN: pamlectabart tismanitin), the Company’s lead Amanitin-based ADC candidate, has been granted Fast Track Designation by the US Food and Drug Administration (FDA). This designation was supported by nonclinical data as […]

Vienna, Austria – October 22, 2025 – GalaTek GmbH, a leading innovator in laboratory automation technologies, and a:head bio AG, a pioneering biotech company specializing in human brain organoid research, today announced a strategic collaboration aimed at advancing the automation of brain organoid workflows. The partnership aims to integrate GalaTek’s advanced robotics and software platforms with […]

Heidelberg, Germany, October 22, 2025 – It’s all about a sustainable, smarter energy future: Clean Tech Innovation Day & Solar TAP Industry Day showed that this can only be achieved with a shared mission and vision. More than 70 participants from science, industry, and start-ups took the opportunity at the Heidelberg Congress Center to exchange […]